Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.
Takabatake D, Kajiwara Y, Ohtani S, Itano Y, Yamamoto M, Kubo S, Ikeda M, Takahashi M, Hara F, Aogi K, Ohsumi S, Ogasawara Y, Nishiyama Y, Hikino H, Matsuoka K, Takahashi Y, Shien T, Taira N, Doihara H. Takabatake D, et al. Among authors: kajiwara y. Breast Cancer. 2018 Nov;25(6):717-722. doi: 10.1007/s12282-018-0877-1. Epub 2018 Jun 11. Breast Cancer. 2018. PMID: 29948957 Clinical Trial.
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
Takahashi Y, Iwamoto T, Suzuki Y, Kajiwara Y, Hatono M, Tsukioki T, Kawada K, Kochi M, Ikeda H, Shien T, Taira N, Matsuoka J, Doihara H, Toyooka S. Takahashi Y, et al. Among authors: kajiwara y. Clin Breast Cancer. 2020 Apr;20(2):117-124.e4. doi: 10.1016/j.clbc.2019.07.001. Epub 2019 Sep 9. Clin Breast Cancer. 2020. PMID: 31570267 Free article.
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments.
Hatono M, Ikeda H, Suzuki Y, Kajiwara Y, Kawada K, Tsukioki T, Kochi M, Suzawa K, Iwamoto T, Yamamoto H, Shien T, Yamane M, Taira N, Doihara H, Toyooka S. Hatono M, et al. Among authors: kajiwara y. Breast Cancer Res Treat. 2021 Jan;185(2):307-316. doi: 10.1007/s10549-020-05957-z. Epub 2020 Oct 9. Breast Cancer Res Treat. 2021. PMID: 33034801 Free article.
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
Kawada K, Taira N, Mizoo T, Suzuki Y, Kajiwara Y, Hatono M, Tsukioki T, Kochi M, Abe Y, Nishiyama K, Iwamoto T, Ikeda H, Shien T, Doihara H, Ishihara S, Kawai H, Kawasaki K, Ishibe Y, Ogasawara Y, Toyooka S. Kawada K, et al. Among authors: kajiwara y. Breast Cancer. 2021 Mar;28(2):478-487. doi: 10.1007/s12282-020-01185-x. Epub 2020 Nov 13. Breast Cancer. 2021. PMID: 33185851 Free article.
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Takabatake D, Kajiwara Y, Ohtani S, Suzuki Y, Yamamoto M, Kubo S, Ikeda M, Takahashi M, Hara F, Aogi K, Ohsumi S, Ogasawara Y, Nishiyama Y, Hikino H, Matsuoka K, Shien T, Taira N, Doihara H. Takabatake D, et al. Among authors: kajiwara y. Acta Med Okayama. 2021 Jun;75(3):357-362. doi: 10.18926/AMO/62231. Acta Med Okayama. 2021. PMID: 34176940 Free article. Clinical Trial.
393 results